Lau J, Bloch P, Schaffer L, et al
Retatrutide can also give hope for new, long-term weight loss choices
Many patients taking GLP-1 receptor agonists for diabetes or weight management report improvements in joint pain, prompting questions about whether these medications directly address musculoskeletal symptoms
While the TTE approach yielded consistent hazard ratios between censored and non-censored analyses, the estimated difference between treatment arms using the change-from-baseline approach was lower without censoring than with censoring, suggesting a potential masking of prasinezumab treatment effects by symptomatic therapy
Hormonal and metabolic differences affect how efficiently the body accesses stored fat
Supporting thyroid function, improving insulin sensitivity, and balancing cortisol levels can significantly accelerate weight loss while improving overall energy and wellness